Digitisation | August 13, 2021
Labcorp, a leader in women’s heath solutions acquires Ovia Health
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21
Substantial reduction in losses
SAB-185 is currently being evaluated in NIH-sponsored Phase 2/3 adaptive trial
The company is eligible for 12 months exclusivity from launch
Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases
The aim is to create new genomics solutions that could combat cancer and advance market access
The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
Company working on COVID vaccine INO 4800
QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab
Subscribe To Our Newsletter & Stay Updated
